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Wednesday, February 19, 2014 721aapproach for evaluation of drug-induced alternation of repolarization processes
in the human cardiomyocytes.
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We have previously shown that reducing Naþ influx by a reduction in peak Naþ
current (INa,peak) in isolated cardiac myocytes leads to a decrease in pro-
arrhythmic Ca2þ waves. However, INa,peak inhibition can result in reduced
conduction velocity and promote wavebreak leading to enhanced arrhythmia
in vivo. Here we test if ranolazine, an inhibitor of late Naþ current (INa,late)
could also reduce the occurrence of Ca2þ waves without potentially problem-
atic reductions in INa,peak. Cells, loaded with fluo-4AM to monitor intracellular
Ca2þ, were stimulated at different pacing rates followed by a one-minute rest
period for wave detection.
10mM ranolazine reduced Ca2þ wave frequency in cells following pacing at
5Hz although less potently than 5mM flecainide (0.1350.02 waves.s1 (flecai-
nide) vs 0.1650.02 waves.s1 (ranolazine), P<0.01). Comparable effects were
achieved when the concentration of ranolazine was increased to 20mM
(0.1450.02 waves.s1 (flecainide) and 0.1850.03 waves.s1 (ranolazine) vs
0.2250.03 waves.s1 (control), P<0.001 and 0.05 respectively) although at
this concentration there is a significant reduction in INa,peak. Ranolazine’s
ability to reduce wave occurrence was tested further under two conditions in
which enhancement of INa,late, would be expected; in the presence of anemone
toxin II and in cells from an established model of chronic heart failure (HF). In
both conditions wave frequency was increased (e.g. 0.0850.01 waves.s1 (HF)
vs 0.0650.01 waves.s1 (control), P<0.05) but ranolazine was not effective at
reducing frequency (0.1950.04 waves.s1 (ranolazine 10mM) vs 0.1950.04
waves.s1 (control), P=0.92).
Ranolazine decreased Ca2þ wave frequency in isolated cardiomyocytes, partic-
ularly at concentrations where INa,peak is reduced. The lack of efficacy in states
of enhanced INa,late suggests specific effects of the drug are less important than
off-target effects on INa,peak. Thus similar dose-limiting side effects as with
conventional INa blockers are expected.
3652-Pos Board B380
Automated Action Potential Recording in Stem Cell-Derived Cardiomyo-
cytes for Proarrhythmia Assessment
Liudmila Polonchuk, Fabian Ha¨usermann, Franz Schuler, Thomas Singer,
Rube´n Alvarez-Sanchez.
Non-Clinical Safety, F. Hoffmann-La Roche AG, Basel, Switzerland.
Development of in vitro toxicity assays based on the human stem cell-derived
cardiomyocytes (SC-CMs) provides an opportunity to assess the specific car-
diac safety end-points early in drug development. The cardiac action potential
(AP) is an established biomarker for cardiac safety and efficacy in humans and
a good detector of proarrhythmic events. However, its utility has been mainly
limited by a low throughput of manual patch clamp and a restricted access
to healthy human cardiomyocytes. The recent progress in automated electro-
physiology combined with availability of human SC-CMs provides an exciting
possibility to measure AP in human cells expressing endogenous cardiac ion
channels.
Electrophysiological properties of human SC-CMs were investigated with spe-
cial focus on establishment of automated cell-based cardiac safety screens.
For the first time assay protocols and procedures were established to measure
and characterize both cardiac AP and the main underlying currents in human
SC-CMs using automated electrophysiology platforms Patchliner(r) and
Synchropatch(r)96 (Nanion Technologies GmbH). Employment of the higher
throughput systems allowed capturing and evaluating AP and cardiac current
profiles in cardiomyocyte cultures revealing specific heterogeneity. Outward
potassium current mainly consisting of slow and rapid delayed rectifier and
Ca2þ-activated components as well as inward cardiac sodium current were
recorded and characterized. Density of L-type Ca2þ current varied with the
type and differentiation status of cardiomyocytes. The inward rectifier potas-
sium current and a pacemaker current could also be measured. These results
demonstrate that functional cardiac currents and appropriate AP present in
human SC-CMs can be successfully recorded by automated electrophysiology
systems.
The automated cardiac AP measurements in human SC-CMs exemplify a novel
screening method for early and sensitive detection of multiple ion channel
effects in vitro completing the current core battery hERG assay and animal
ECG measurements in pre-clinical safety assessment.3653-Pos Board B381
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Auditory stimuli are a recognized trigger of arousal-induced torsade de pointes
(TdP) in patients with Long QT Syndrome Type 2 (LQT2). There is also clear
evidence that the effect of auditory stimulation to modulate ventricular repolar-
ization is more pronounced in women than men, and that female sex is an
independent risk factor for long-QT syndrome and increased propensity for
torsade de pointes arrhythmias. Indeed, females with LQT2 experience a
greater than nine-fold increase in the risk for arousal-triggered cardiac events
compared with men in the same age group after the onset of adolescence. In
order to reveal the interactions and contributions of rapid bursts of sympathetic
activity, sex steroid hormones and differences in ion channels expression in
male and female hearts, we have developed a model of the female cardiac
cell that includes sex stereoid hormones and experimentally observed reduction
in expression of Connexin 43 (Cx43) and repolarization currents IK1, IKr, IKs,
and Ito compared to males. These changes were incorporated into the
O’Hara-Rudy human ventricular cell model. In order to account for sympathet-
ically mediated arousal, we also incorporated subcellular signaling pathways
linked to beta-adrenergic receptors. Finally, Long-QT 2 mutations were incor-
porated into the model. The model simulations predict that the high estrogen
levels and low progesterone levels that occur during the follicular phase of
the menstrual cycle in females and the interplay between larger net inward
currents set the stage for action potential prolongation that in combination
with sudden bursts of beta-adrenergic signaling leads to a profoundly increased
likelihood of arrhythmia triggers in females compared to males in singe cells
and 1-D tissue. The model also predicts a high degree of protection by testos-
terone in males against arrhythmia triggering.
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It is well known that extracellular calcium concentration ([Ca2þ]o) affects
cardiac action potential duration (APD): their inverse relationship has been
experimentally observed in vivo and in vitro. Both shortening and prolongation
of action potential (AP) are associated with an increased risk of arrhythmias
and extracellular calcium variations may occur in many clinical contexts.
Computational modeling could be a useful tool to explore this phenomenon:
however, most of the commonly used ventricular cell models are not able
to reproduce [Ca2þ]o effects on AP duration properly, i.e. they respond
to [Ca2þ]o increase with AP prolongation. The aim of this study has been to
modify the most recent human ventricular AP model, in order to improve its
response to [Ca2þ]o variations.
The O’Hara-Rudy AP model (ORd) has been used as basis. Its L-type calcium
current formulation has been replaced by a novel Markov model. Calcium-
dependent inactivation (CDI) has been strengthened, with respect to the
Voltage-dependent one (VDI). All inactivation rates are actually voltage-
dependent: Ca2þ modulates only the fraction of channels working in CDI
mode, which is 10 times faster than the VDI. After few minor changes, all
involving Ca2þ-handling, the modified model has been validated against a
wide set of experimental data. Simulations were run with the original and
modified models considering [Ca2þ]o ranging from 1 to 3 mM.
In control ([Ca2þ]o =1.8mM), the modified and original ORd model APs and
ionic currents were very similar. However, when changing [Ca2þ]o from 0.9
to 2.7 mM, APDs varied in an opposite way: þ19% vs 12%, original and
modified models respectively. Therefore, the modified model may be used to
explore in silico electrolyte changes effects on AP. Moreover, these results
suggest that CDI mechanism is usually underestimated in ventricular human
AP models.
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The property of human induced pluripotent stem cell-derived cardiomyocytes
(hiPSC-CMs) to carry the same genetic mutations of the patient’s cardiomyo-
cytes, made them promising in-vitro patient-specific disease cell models.
